Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4710 -0.0080 (-1.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > 12 Health Care Stocks Moving In Thursday's After-Market Session September 21, 2023 Via Benzinga Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here September 21, 2023 The U.S. Patent and Trademark Office (USPTO) has issued a new patent granting IP rights for the novel composition of matter and methods of use on the psilocybin-based molecules series EVM301 to its... Via Benzinga Topics Derivatives Intellectual Property Exposures Derivatives Intellectual Property Enveric Biosciences Expands IP Portfolio with New U.S. Patent for Novel Carboxylated Psilocybin Derivatives Supporting its EVM301 Series of Drug Candidates September 20, 2023 From Enveric Biosciences Via Business Wire Porch Group And 2 Other Stocks Under $3 Insiders Are Buying September 20, 2023 The Dow Jones closed lower by over 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More September 18, 2023 Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next Via Benzinga Exposures Product Safety Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023 September 18, 2023 From Enveric Biosciences Via Business Wire Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Enveric Biosciences Files Provisional Patent Application for AI-based Computational Methods for Identifying and Optimizing Novel Tryptamine Derivatives September 11, 2023 From Enveric Biosciences Via Business Wire Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Via Benzinga Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives September 05, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences to Present at H.C. Wainwright 25th Annual Global Conference August 30, 2023 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 29, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday August 29, 2023 It's time for another dive into the biggest pre-market stock movers as we check out the shares worth watching on Tuesday! Via InvestorPlace Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment August 28, 2023 The USPTO issued a patent covering Enveric Biosciences’ (NASDAQ: ENVB) lead candidate EB-373, a psilocin prodrug under development for the treatment of anxiety disorder. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More August 28, 2023 Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials Via Benzinga Enveric Biosciences Strengthens Intellectual Property Portfolio with New U.S. Patent for Tryptamine-derived Prodrugs August 28, 2023 From Enveric Biosciences Via Business Wire Marijuana Stock Movers For August 23, 2023 August 23, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 24, 2023 August 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports August 21, 2023 Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds Via Benzinga Topics Cannabis Economy Exposures Cannabis Interest Rates Marijuana Stock Movers For August 22, 2023 August 22, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program August 21, 2023 Enveric Biosciences (NASDAQ: ENVB) has completed manufacturing of drug material enabling the completion of preclinical work for EB-373 including all bioanalytical method validation, GLP toxicology and... Via Benzinga Enveric Biosciences Completes Manufacturing of EB-373 to Supply Drug Material for Completion of Preclinical Program August 21, 2023 From Enveric Biosciences Via Business Wire Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024 August 14, 2023 Next-gen psychedelics business Enveric Biosciences (NASDAQ: ENVB) reported its unaudited financial results for the second quarter of 2023 ended June 30. Results show: Via Benzinga Cannabis Stock Gainers And Losers From August 16, 2023 August 16, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published Via Benzinga Marijuana Stock Movers For August 15, 2023 August 15, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results August 14, 2023 From Enveric Biosciences, Inc. Via Business Wire Cannabis Stock Gainers And Losers From August 11, 2023 August 11, 2023 Via Benzinga Topics Cannabis Exposures Cannabis 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 08, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.